London stocks were still flat by midday on Wednesday ahead of the latest US inflation reading. The FTSE 100 was steady at 8,780.40. Russ Mould, investment director at AJ Bell, said: "US inflation ...

"The FTSE 100 opened flat this morning, and after posting another record high yesterday it's still riding on a wave of enthusiasm. US inflation data has scope to upset the apple card later today, but ...

Kenvue's improvements in marketing and management could drive future growth. Read why there is potential for a turnaround for ...

Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company ...

About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate ...

GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

ViiV Healthcare has secured European Commission approval for its long-acting HIV treatment, Vocabria + Rekambys, for adolescents aged 12 and olde ...

GSK plc (LSE/NYSE: GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has today announced that the European ...

February is observed as American Heart Month, a period dedicated to raising awareness about heart health. The first American Heart ...

Complex legal battle concerns ‘skinny label’ strategy used by generic drug makers, prompting a $235 million award | Pharma ...

GSK plc GSK recently announced that EMA has accepted the regulatory filing seeking approval for its IL-5 inhibitor ...

GSK announces depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP: London, UK Wednesday, January 29, 2025, 17:00 Hrs [IS ...